The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 17, 2023
Filed:
Apr. 30, 2021
Applicant:
Immatics Biotechnologies Gmbh, Tuebingen, DE;
Inventors:
Toni Weinschenk, Aichwald, DE;
Andrea Mahr, Tuebingen, DE;
Jens Fritsche, Dusslingen, DE;
Phillip Mueller, Kassel, DE;
Anita Wiebe, Ruebgarten, DE;
Sarah Kutscher, Tuebingen, DE;
Assignee:
IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen, DE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/04 (2006.01); C07K 7/06 (2006.01); C07K 7/00 (2006.01); A61K 35/17 (2015.01); C07K 16/18 (2006.01); G01N 33/68 (2006.01); C07K 14/435 (2006.01); C07K 7/08 (2006.01); A61K 51/10 (2006.01); A61K 35/12 (2015.01); C12N 5/0783 (2010.01); C12N 15/115 (2010.01); C07K 14/725 (2006.01); C07K 14/74 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 35/17 (2013.01); A61K 38/04 (2013.01); C07K 7/00 (2013.01); C07K 7/06 (2013.01); C07K 14/435 (2013.01); C07K 16/18 (2013.01); G01N 33/6803 (2013.01); A61K 39/00111 (2018.08); A61K 51/1057 (2013.01); A61K 2035/124 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/5158 (2013.01); C07K 7/08 (2013.01); C07K 14/7051 (2013.01); C07K 14/70539 (2013.01); C07K 2317/70 (2013.01); C07K 2319/40 (2013.01); C12N 5/0636 (2013.01); C12N 15/115 (2013.01); C12N 2310/16 (2013.01); C12N 2501/998 (2013.01);
Abstract
A peptide consists of the amino acid sequence KLSPTVVGL (SEQ ID NO: 6) in the form of a pharmaceutically acceptable salt, in which the peptide has the ability to bind to an MHC class-I molecule and, when bound to MHC, is capable of being recognized by CD8 T cells. A composition contains a peptide consisting of the amino acid sequence KLSPTVVGL (SEQ ID NO: 6), an adjuvant, and a pharmaceutically acceptable carrier.